Bristol-Myers, Sanofi Fined $834M In Hawaii Over Plavix: Bloomberg

Loading...
Loading...
  • Bristol-Myers Squibb Co (NYSE: BMY) and Sanofi SA (NASDAQ: SNY) were ordered to pay the state of Hawaii more than $834 million for illegally marketing their blood-thinning drug Plavix, Bloomberg reports.
  • Hawaii Attorney General Clare Connors’ lawyers showed the companies didn’t adequately disclose the blood thinner was ineffective for as many as 30% of users in the state, the judge said.
  • “The court’s ruling is unsupported by the law and at odds with the evidence at trial,” the companies said in a joint statement. The companies said they would appeal.
  • Price Action: BMY shares were down 0.5% at $59.68, and SNY decreased 0.53% at $47.33 in market trading hours on the last check Tuesday.
Posted In: BiotechNewsHealth CareFDALegalTop StoriesGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...